Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ID-RCB Number:2022-A02649-34 | Other Identifier | ID-RCB Number:2022-A02649-34 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| URC-CIC Paris Descartes Necker Cochin | OTHER |
Not provided
Not provided
Not provided
Not provided
This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their daily prevention medication and their rescue medication for asthma symptoms. If a child misses several days of prevention medication or uses their rescue inhaler frequently, their doctor receives an alert and can schedule a video consultation to adjust their treatment. Fifty children aged 4-12 years with asthma will participate for 8 months, with half using this digital system and half receiving usual care. The study will measure whether this new approach is practical and acceptable to families and doctors, and will look at its effects on asthma control, quality of life, and healthcare use. The results will help design a larger study to fully test if this digital approach could improve asthma care for children.
Asthma is the most common chronic illness in children. In France, two-thirds of children have uncontrolled asthma, meaning they experience symptoms and occasional asthma attacks.
The digital revolution has enabled the development of connected devices, particularly smart inhalers, which collect objective information for assessing asthma from patients' homes. The Covid-19 pandemic has further accelerated the adoption of telemedicine. These new approaches represent a significant shift in paediatric asthma management, offering opportunities for more effective treatment methods.
As a precursor to a larger investigation, this pilot study hypothesises that digital asthma management using proactive remote care through telemedicine consultations triggered by connected device alerts may improve childhood asthma control compared to current management approaches.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Digital medicine | Experimental | Active telemonitoring using real-time data from digital inhalers |
|
| Standardized medicine | Active Comparator | The patients are monitored as usual according to the standard care protocol. Patients will receive 2 digital inhalers, but only to record their treatment use. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Active telemonitoring using real-time data from digital inhalers. | Device | Telemonitoring system relying on the use of 2 digital inhalers FindAir ONE for pMDI, one for the controller the other for the reliever treatment. Active telemonitoring using real-time data from digital inhalers. Investigators will be alerted by email if a child:
In these cases, investigators will be asked to schedule a teleconsultation within 2 working days with the family and to adapt treatments as needed. They may ask the family to use the portable spirometer and oximeter if necessary. No systematic consultation will be planned. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in asthma severity measured by the Composite Asthma Severity Index (CASI) | The CASI is a validated composite score that evaluates asthma severity by incorporating measures of asthma symptoms, exacerbations, lung function, and treatment level. The change in CASI score will be compared between groups, calculated as the difference between the final score (at 8 months) and the baseline score. Lower scores indicate less severe asthma. The CASI ranges from 0 to 17, with higher scores meaning a higher severity (worse outcome). | At the inclusion visit (baseline) and 8 months (+/- 1 month) (end of study) in each group |
| Measure | Description | Time Frame |
|---|---|---|
| Asthma control | Evolution in the overall Childhood Asthma Control Test (c-ACT) score. The c-ACT (Childhood Asthma Control Test) will be used to evaluate the evolution of asthma control. The c-ACT ranges from 0 min to 27 max, with higher scores meaning better asthma control (better outcome). | At the inclusion visit (baseline) and 8 months (+/- 1 month) (end of study) in each group |
Not provided
Inclusion Criteria:
Aged 4 to 12, whose asthma has been diagnosed by a physician
Followed up for their asthma by a pediatrician or pediatric pulmonologist
With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
With social security
Whose parents or legal guardian(s):
Non-inclusion Criteria:
Exclusion Criteria:
- Patient who did not use the system within 15 days of the inclusion visit
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| David DUMMOND, MD, PhD | Contact | 01 87 89 20 28 | +33 | david.drummond@aphp.fr |
| sarah BOUCHARD, Project manager | Contact | 01 42 19 28 79 | +33 | sarah.bouchard@ahp.fr |
| Name | Affiliation | Role |
|---|---|---|
| David DUMMOND, MD, PhD | Hôpital Necker Enfants Malades AP-HP | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Necker Enfants Malades AP-HP | Recruiting | Paris | 75015 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Standard | Other | Standardized care + passive recording of asthma treatment use (controller and reliever treatments) using digital inhalers |
|
| Severe exacerbations requiring oral steroids | Severe exacerbations (defined as an exacerbation requiring oral corticosteroid therapy): number of severe exacerbations per patient and percentage of patients with at least one severe exacerbation | During the eight-month follow up period in each group |
| Severe exacerbations requiring emergency department visit and/or hospital admission. | Severe exacerbations requiring emergency department visits and/or hospitali admission: number per patient and percentage of patients with at least one | During the eight-month follow up period in each group |
| Children's lung function | Evolution of lung function assessed by the predicted percentage of the forced expiratory volume in one second (FEV1) in children aged 7 to 12 years | At the inclusion visit (baseline) and 8 months (+/- 1 month) (end study) in each group |
| Quality of life questionnaire | Children (aged 7 -12 years) were assessed by the mini Pediatric Asthma Quality of Life Questionnaire (mPAQLQ). Their parents were assessed by the Pediatric Asthma Caregivers' Quality of Life. | At the inclusion visit (baseline) and 8 months (+/- 1 month) (end of study) in each group |
| Adherence | The adherence of patients to their maintenance treatment, automatically recorded via digital inhalers, defined as the number of doses taken divided by the number of doses prescribed x 100: average percentage of adherence | During the eight-month follow up period in each group |
| Reliever treatment | Use of reliever treatment (salbutamol) is automatically recorded via digital inhalers: average number of uses per each patient | During the eight-month follow up period in each group |
| Number of teleconsultations/consultations | Average number of consultations/teleconsultations per patient, scheduled and unscheduled, and their average cumulative duration per patient | During the eight-month follow up period in each group |
| Children participation | The child's speaking time compared to the total speaking time (child + parent + doctor), expressed as a percentage was determined from video recordings. The number of the child's speech turns compared to the total number of speech turns (child + parent + doctor), expressed as a percentage. The number of complete thoughts, or "utterances", of the child compared to the total number of complete thoughts, expressed as a percentage. The child's non-verbal communication, analyzed by a module of the Roter Interactive Assessment System | During the eight-month follow up period in each group |
| Absenteeism | Number of days of asthma-related absenteeism (from school for children and work for parents), per patient | During the eight-month follow up period in each group |
| Satisfaction of parents | Assessed by the proportion of parents in the experimental group responding on a custom questionnaire that they wish to continue the digital management experience and the reason for their choice | After 8 months (+/- 1 month) (end of study) |
| Satisfaction of doctors | Assessed by the proportion of doctors in the experimental group responding on a custom questionnaire that they wish to continue the digital management experience and the reason for their choice | After 8 months (+/- 1 month) (end of study) |